Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01097928 · ClinicalTrials.gov registry record

Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT

A clinical trial of Pulmonary Embolism, sponsored by Stanford University.

Completed
Registry status
333
Enrollment target
1
Study location

NCT01097928 is a study of Pulmonary Embolism that has completed, run by Stanford University. The registered enrollment target is 333 participants, below the 3,052-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01097928, a study of Pulmonary Embolism, has completed, sponsored by Stanford University.

COMPLETED
Registry status
333 participants
Enrollment target
1
Study location

Study Summary

A prospective observational study to evaluate the safety and effectiveness data of catheter-directed therapy (CDT) including percutaneous mechanical thrombectomy (PMT) for treatment of acute pulmonary embolism (PE)

Conditions Studied

Interventions

  • PROCEDURE Catheter directed debulking of Pulmonary Embolus

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 333 participants
Start Date 2010-01
Est. Completion 2020-01-31

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01097928

The ClinicalTrials.gov registry entry for NCT01097928 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,052-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (89% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Catheter directed debulking of Pulmonary Embolus is the first listed.

NCT01097928 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01097928 about?

NCT01097928 is a clinical study titled "Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT". A prospective observational study to evaluate the safety and effectiveness data of catheter-directed therapy (CDT) including percutaneous mechanical thrombectomy (PMT) for treatment of acute pulmonary embolism (PE)

What is the current status of trial NCT01097928?

This trial is currently completed. The enrollment target is 333 participants. The study started on 2010-01. Estimated completion is 2020-01-31.

What conditions does trial NCT01097928 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT01097928?

The interventions under investigation include: Catheter directed debulking of Pulmonary Embolus (PROCEDURE).

Who is sponsoring clinical trial NCT01097928?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01097928 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.